M1 KLINIKEN AG (M12.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:M12 - DE000A0STSQ8 - Common Stock
17.26 EUR
+0.12 (+0.7%)
Overall M12 gets a fundamental rating of 6 out of 10. We evaluated M12 against 30 industry peers in the Health Care Providers & Services industry. M12 scores excellent points on both the profitability and health parts. This is a solid base for a good stock. M12 has a decent growth rate and is not valued too expensively. These ratings would make M12 suitable for quality investing!
1. Profitability
1.1 Basic Checks
- M12 had positive earnings in the past year.
- In the past year M12 had a positive cash flow from operations.
- Each year in the past 5 years M12 has been profitable.
- M12 had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With an excellent Return On Assets value of 8.73%, M12 belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
- M12's Return On Equity of 15.03% is fine compared to the rest of the industry. M12 outperforms 80.00% of its industry peers.
- With an excellent Return On Invested Capital value of 13.44%, M12 belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for M12 is in line with the industry average of 6.46%.
- The last Return On Invested Capital (13.44%) for M12 is above the 3 year average (7.72%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.73% | ||
| ROE | 15.03% | ||
| ROIC | 13.44% |
ROA(3y)5.18%
ROA(5y)4.73%
ROE(3y)9.59%
ROE(5y)9.22%
ROIC(3y)7.72%
ROIC(5y)6.16%
1.3 Margins
- Looking at the Profit Margin, with a value of 5.00%, M12 belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
- M12's Profit Margin has declined in the last couple of years.
- Looking at the Operating Margin, with a value of 8.52%, M12 is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of M12 has declined.
- M12's Gross Margin of 19.29% is in line compared to the rest of the industry. M12 outperforms 46.67% of its industry peers.
- In the last couple of years the Gross Margin of M12 has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.52% | ||
| PM (TTM) | 5% | ||
| GM | 19.29% |
OM growth 3Y27.08%
OM growth 5Y-5.31%
PM growth 3Y18.61%
PM growth 5Y-17.82%
GM growth 3Y2.18%
GM growth 5Y-14.45%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), M12 is creating value.
- The number of shares outstanding for M12 has been reduced compared to 1 year ago.
- Compared to 5 years ago, M12 has more shares outstanding
- The debt/assets ratio for M12 is higher compared to a year ago.
2.2 Solvency
- M12 has an Altman-Z score of 5.59. This indicates that M12 is financially healthy and has little risk of bankruptcy at the moment.
- With an excellent Altman-Z score value of 5.59, M12 belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
- The Debt to FCF ratio of M12 is 0.70, which is an excellent value as it means it would take M12, only 0.70 years of fcf income to pay off all of its debts.
- M12's Debt to FCF ratio of 0.70 is amongst the best of the industry. M12 outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.05 indicates that M12 is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.05, M12 belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.7 | ||
| Altman-Z | 5.59 |
ROIC/WACC1.83
WACC7.35%
2.3 Liquidity
- A Current Ratio of 2.06 indicates that M12 has no problem at all paying its short term obligations.
- The Current ratio of M12 (2.06) is better than 90.00% of its industry peers.
- M12 has a Quick Ratio of 1.35. This is a normal value and indicates that M12 is financially healthy and should not expect problems in meeting its short term obligations.
- M12's Quick ratio of 1.35 is amongst the best of the industry. M12 outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.36% over the past year.
- Measured over the past 5 years, M12 shows a small growth in Earnings Per Share. The EPS has been growing by 7.97% on average per year.
- The Revenue has been growing slightly by 6.52% in the past year.
- Measured over the past years, M12 shows a very strong growth in Revenue. The Revenue has been growing by 34.44% on average per year.
EPS 1Y (TTM)10.36%
EPS 3Y21.62%
EPS 5Y7.97%
EPS Q2Q%25%
Revenue 1Y (TTM)6.52%
Revenue growth 3Y2.54%
Revenue growth 5Y34.44%
Sales Q2Q%9.42%
3.2 Future
- The Earnings Per Share is expected to grow by 19.18% on average over the next years. This is quite good.
- The Revenue is expected to grow by 8.24% on average over the next years. This is quite good.
EPS Next Y5.19%
EPS Next 2Y14.78%
EPS Next 3Y19.18%
EPS Next 5YN/A
Revenue Next Year6.09%
Revenue Next 2Y6.66%
Revenue Next 3Y6.53%
Revenue Next 5Y8.24%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 18.36, M12 is valued on the expensive side.
- The rest of the industry has a similar Price/Earnings ratio as M12.
- M12 is valuated rather cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 14.88, the valuation of M12 can be described as correct.
- The rest of the industry has a similar Price/Forward Earnings ratio as M12.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.26, M12 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.36 | ||
| Fwd PE | 14.88 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of M12 indicates a somewhat cheap valuation: M12 is cheaper than 70.00% of the companies listed in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of M12 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.7 | ||
| EV/EBITDA | 8.38 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- M12 has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as M12's earnings are expected to grow with 19.18% in the coming years.
PEG (NY)3.54
PEG (5Y)2.31
EPS Next 2Y14.78%
EPS Next 3Y19.18%
5. Dividend
5.1 Amount
- M12 has a Yearly Dividend Yield of 2.88%. Purely for dividend investing, there may be better candidates out there.
- M12's Dividend Yield is rather good when compared to the industry average which is at 1.73. M12 pays more dividend than 86.67% of the companies in the same industry.
- M12's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.88% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
DPN/A
EPS Next 2Y14.78%
EPS Next 3Y19.18%
M1 KLINIKEN AG / M12.DE FAQ
Can you provide the ChartMill fundamental rating for M1 KLINIKEN AG?
ChartMill assigns a fundamental rating of 6 / 10 to M12.DE.
What is the valuation status for M12 stock?
ChartMill assigns a valuation rating of 4 / 10 to M1 KLINIKEN AG (M12.DE). This can be considered as Fairly Valued.
How profitable is M1 KLINIKEN AG (M12.DE) stock?
M1 KLINIKEN AG (M12.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for M12 stock?
The Price/Earnings (PE) ratio for M1 KLINIKEN AG (M12.DE) is 18.36 and the Price/Book (PB) ratio is 2.87.
What is the financial health of M1 KLINIKEN AG (M12.DE) stock?
The financial health rating of M1 KLINIKEN AG (M12.DE) is 8 / 10.